Tic Disorders Clinical Trials
2 recruiting trials for Tic Disorders. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Tic Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Massachusetts Eye and Ear Infirmary (1), Institut National de la Santé Et de la Recherche Médicale, France (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is DystoniaNet-based diagnosis of isolated dystonia (diagnostic_test, 1 trial), followed by EEG, MRI.
Track Tic Disorders trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.
Objective Characterizatoion of Repetitive Behaviors
Introduction: Repetitive behaviors (RB) constitute a broad range of symptoms across different psychiatric/neurologic disorders. The most famous are stereotypies (found in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Tic Disorders, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Tic Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Tic Disorders, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.